BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31892568)

  • 21. Clinical Implications of Mismatch Repair Status in Patients With High-risk Stage II Colon Cancer.
    Baek DW; Kang BW; Lee SJ; Kim HJ; Park SY; Park JS; Choi GS; Baek JH; Kim JG
    In Vivo; 2019; 33(2):649-657. PubMed ID: 30804154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.
    Gao XH; Yu GY; Gong HF; Liu LJ; Xu Y; Hao LQ; Liu P; Liu ZH; Bai CG; Zhang W
    Sci Rep; 2017 Aug; 7(1):7882. PubMed ID: 28801584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.
    Nehls O; Okech T; Hsieh CJ; Enzinger T; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Hass HG; Arkenau HT; Hartmann JT; Porschen R; Gregor M; Klump B
    Br J Cancer; 2007 May; 96(9):1409-18. PubMed ID: 17426704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary tumor location in stage III colon cancer has prognostic impact on subsequent liver metastasis.
    Liao CK; Chiang JM; Tsai WS; You JF; Hsieh PS; Hung HY; Chen HH; Tang RP; Chen JS; Yeh CY
    J Surg Oncol; 2018 Dec; 118(8):1301-1310. PubMed ID: 30408183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
    Huemer F; Thaler J; Piringer G; Hackl H; Pleyer L; Hufnagl C; Weiss L; Greil R
    BMC Cancer; 2018 Jan; 18(1):11. PubMed ID: 29298682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance].
    Xu KY; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):285-9. PubMed ID: 19434540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified complete mesocolic excision with central vascular ligation for the treatment of right-sided colon cancer: long-term outcomes and prognostic factors.
    Cho MS; Baek SJ; Hur H; Soh Min B; Baik SH; Kyu Kim N
    Ann Surg; 2015 Apr; 261(4):708-15. PubMed ID: 25072438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes.
    Lee MS; Menter DG; Kopetz S
    J Natl Compr Canc Netw; 2017 Mar; 15(3):411-419. PubMed ID: 28275039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression.
    Mukund K; Syulyukina N; Ramamoorthy S; Subramaniam S
    BMC Cancer; 2020 Apr; 20(1):317. PubMed ID: 32293332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
    Kotha NV; Baumgartner JM; Veerapong J; Cloyd JM; Ahmed A; Grotz TE; Leiting JL; Fournier K; Lee AJ; Dineen SP; Dessureault S; Clarke C; Mogal H; Zaidi MY; Russell MC; Patel SH; Sussman JJ; Dhar V; Lambert LA; Hendrix RJ; Abbott DE; Pokrzywa C; Lafaro K; Lee B; Greer JB; Fackche N; Lowy AM; Kelly KJ
    Ann Surg Oncol; 2019 Jul; 26(7):2234-2240. PubMed ID: 31016486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients.
    Lind GE; Guriby M; Ahlquist T; Hussain I; Jeanmougin M; Søreide K; Kørner H; Lothe RA; Nordgård O
    Clin Epigenetics; 2017; 9():97. PubMed ID: 28878843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.
    Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT
    Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
    Shida D; Tanabe T; Boku N; Takashima A; Yoshida T; Tsukamoto S; Kanemitsu Y
    Ann Surg Oncol; 2019 May; 26(5):1358-1365. PubMed ID: 30719633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.
    Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Hashiguchi Y; Sugihara K; Watanabe T
    Int J Surg; 2014; 12(9):925-30. PubMed ID: 25091400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
    Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
    N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients.
    Brungs D; Aghmesheh M; de Souza P; Ng W; Chua W; Carolan M; Clingan P; Healey E; Rose J; Tubaro T; Ranson M
    BMC Cancer; 2017 Apr; 17(1):251. PubMed ID: 28390415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Better survival in right-sided versus left-sided stage I - III colon cancer patients.
    Warschkow R; Sulz MC; Marti L; Tarantino I; Schmied BM; Cerny T; Güller U
    BMC Cancer; 2016 Jul; 16():554. PubMed ID: 27464835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy.
    Gallois C; Taieb J; Le Corre D; Le Malicot K; Tabernero J; Mulot C; Seitz JF; Aparicio T; Folprecht G; Lepage C; Mini E; Van Laethem JL; Emile JF; Laurent-Puig P;
    Clin Cancer Res; 2018 Oct; 24(19):4745-4753. PubMed ID: 29921730
    [No Abstract]   [Full Text] [Related]  

  • 40. Right-Sided and Left-Sided Colon Cancers are Two Distinct Disease Entities: an Analysis of 200 Cases in Pakistan.
    Hussain M; Waqas O; Hassan U; Loya A; Akhtar N; Mushtaq S; Yusuf MA; Syed AA
    Asian Pac J Cancer Prev; 2016; 17(5):2545-8. PubMed ID: 27268627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.